Article

May 6, 2022

AJMC® in the Press, May 6, 2022

Author(s):

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article published by OncLive referenced a Peer Exchange series by The American Journal of Managed Care^® (AJMC^®), titled “Advancing Precision Medicine Through Comprehensive Genomic Profiling (CGP).” The series provides payer and clinician insight regarding the integration of CGP into routine clinical practice to help oncologists make more informed treatment decisions for patients with cancer.

Several conference coverage articles and a video posted on AJMC.com, the website of AJMC^®, were featured in the Comparative Effectiveness Research Daily Newsfeed distributed by the National Pharmaceutical Council. The content referenced include:

Related Videos

Tiara Green MSEd

Tiara Green MSEd

Michael Morse, MD, Duke Cancer Center

Screenshot of Ryan Nix, PharmD, during a video interview

Leslie Fish, PharmD.

Mila Felder, MD, FACEP

Shawn Gremminger

Dr Lucy Langer

Dr Lucy Langer

Edward Arrowsmith, MD, MPH

Related Content

We Need to Act Earlier to Address the Silent Crisis of Kidney Disease, Inadequate Federal Support

September 20th 2024

We Need to Act Earlier to Address the Silent Crisis of Kidney Disease, Inadequate Federal Support

Jeffrey Silberzweig, MD

The author discusses a program to prevent kidney decline and progression to dialysis by offering education, support services, and help navigating the health care system to those most at risk.

May 7th 2024

CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection

Brooke McCormick

On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.

While shares varied by payer market, 73.6% of retail prescriptions overall were attributed to CVS Caremark, Optum Rx, and Express Scripts in the study. | Image credit: DedMityay - stock.adobe.c

September 10th 2024

A Highly Concentrated PBM Market Highlights Need for Policy Changes

The findings may help inform policy changes at the federal level aiming to address unfair and deceptive pharmacy benefit manager (PBM) practices.

Managed Care Cast

May 26th 2023

Navigating Medicare's Part D Subsidy Program to Achieve Value-Based Care

On this episode of Managed Care Cast, we speak with the lead researcher from a study published in the May 2023 issue of The American Journal of Managed Care® about the impact of low-income subsidies on the uptake and equitable use of expensive orally administered antimyeloma therapy.

August 19th 2024

Back to School: Locally Sponsored IVBM Events on Tap for August, September

A review of the upcoming schedule of the Institute for Value-Based Medicine.

AJMC

August 8th 2024

Hospitals’ Strategies to Reduce Costs and Improve Quality: Survey of Hospital Leaders

Gmerice Hammond, MD, MPH Tierney Lanter, BS Fengxian Wang, PhD R. J. Waken, PhD Jie Zheng, PhD Arnold M. Epstein, MD, MA E. John Orav, PhD Karen E. Joynt Maddox, MD, MPH

Hospitals pursue a broad range of efforts to improve quality, with those participating in bundled payments attempting to reduce postacute care to a greater degree than nonparticipants.

Related Content

We Need to Act Earlier to Address the Silent Crisis of Kidney Disease, Inadequate Federal Support

September 20th 2024

We Need to Act Earlier to Address the Silent Crisis of Kidney Disease, Inadequate Federal Support

Jeffrey Silberzweig, MD

The author discusses a program to prevent kidney decline and progression to dialysis by offering education, support services, and help navigating the health care system to those most at risk.

May 7th 2024

CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection

Brooke McCormick

On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.

While shares varied by payer market, 73.6% of retail prescriptions overall were attributed to CVS Caremark, Optum Rx, and Express Scripts in the study. | Image credit: DedMityay - stock.adobe.c

September 10th 2024

A Highly Concentrated PBM Market Highlights Need for Policy Changes

The findings may help inform policy changes at the federal level aiming to address unfair and deceptive pharmacy benefit manager (PBM) practices.

Managed Care Cast

May 26th 2023

Navigating Medicare's Part D Subsidy Program to Achieve Value-Based Care

On this episode of Managed Care Cast, we speak with the lead researcher from a study published in the May 2023 issue of The American Journal of Managed Care® about the impact of low-income subsidies on the uptake and equitable use of expensive orally administered antimyeloma therapy.

August 19th 2024

Back to School: Locally Sponsored IVBM Events on Tap for August, September

A review of the upcoming schedule of the Institute for Value-Based Medicine.

AJMC

August 8th 2024

Hospitals’ Strategies to Reduce Costs and Improve Quality: Survey of Hospital Leaders

Gmerice Hammond, MD, MPH Tierney Lanter, BS Fengxian Wang, PhD R. J. Waken, PhD Jie Zheng, PhD Arnold M. Epstein, MD, MA E. John Orav, PhD Karen E. Joynt Maddox, MD, MPH

Hospitals pursue a broad range of efforts to improve quality, with those participating in bundled payments attempting to reduce postacute care to a greater degree than nonparticipants.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions